Loading
Surgeon-scientist who led the TCGA endometrial cancer study that created today's four molecular subtypes.
Douglas Levine led the TCGA integrated genomic characterisation of endometrial carcinoma, which defined the POLE ultramutated, microsatellite-unstable, copy-number-low and copy-number-high (p53-abnormal) subtypes now embedded in international guidelines and trials. He also co-led the TCGA ovarian cancer analysis and directs gynaecologic oncology at NYU Langone, where his laboratory studies the origins of high-grade serous cancer.
Shares TCGA Pan-Cancer Atlas: 10,000 tumours across 33 cancer types, classified by molecular features, Whole-exome & whole-genome sequencing.
Shares Endometrial cancer, Ovarian cancer and the tag endometrial.
Shares TCGA Pan-Cancer Atlas: 10,000 tumours across 33 cancer types, classified by molecular features and the tag genomics.
Shares Whole-exome & whole-genome sequencing and the tag genomics.
Shares Whole-exome & whole-genome sequencing and the tag genomics.
Shares Whole-exome & whole-genome sequencing and the tag genomics.
Shares Endometrial cancer, Ovarian cancer and the tag endometrial.
Shares Whole-exome & whole-genome sequencing and the tag genomics.